Janvier Group Biosciences Revenue

Biotechnology Research • • 1-10 Employees

Janvier Group Biosciences revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Janvier Group Biosciences

Thomas Janvier

CEO

Company overview

Headquarters	XX
Website	janvier-group.com
NAICS	541714
Employees	1-10

About Janvier Group Biosciences

Since its origins in 1960, Janvier Group has evolved into an essential partner in Drug Discovery, Preclinical Research and Bioproduction, providing clients worldwide with a unique combination of models and innovative solutions. We leverage the latest technologies to deliver well-characterized in vitro, in vivo, and custom-created models, as well as a range of tailored services to support your research from hit identification to candidate selection, with strong expertise in understanding mechanisms of action. Janvier Group operates internationally with a team of over 750 dedicated experts.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Janvier Group Biosciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Janvier Group Biosciences has never raised funding before.

Frequently asked questions

Janvier Group Biosciences is located in XX.

Janvier Group Biosciences generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Janvier Group Biosciences has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Janvier Group Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Janvier Group Biosciences

Thomas Janvier

CEO

4.8

40,000 users